Interactions between S100A9 and Alpha-Synuclein: Insight from NMR Spectroscopy.

AFM FTIR LDH cell toxicity tests MTT NMR S100A9 ThT fluorescence assay amyloid proteins fibrils synuclein

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jun 2022
Historique:
received: 25 05 2022
revised: 14 06 2022
accepted: 15 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

S100A9 is a pro-inflammatory protein that co-aggregates with other proteins in amyloid fibril plaques. S100A9 can influence the aggregation kinetics and amyloid fibril structure of alpha-synuclein (α-syn), which is involved in Parkinson's disease. Currently, there are limited data regarding their cross-interaction and how it influences the aggregation process. In this work, we analyzed this interaction using solution 19F and 2D

Identifiants

pubmed: 35743221
pii: ijms23126781
doi: 10.3390/ijms23126781
pmc: PMC9224231
pii:
doi:

Substances chimiques

Amyloid 0
Calgranulin B 0
alpha-Synuclein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Latvijas Organiskās Sintēzes Institūts
ID : 1.1.1.2/VIAA/2/18/374
Organisme : Latvijas Organiskās Sintēzes Institūts
ID : 1.1.1.2/VIAA/2/18/379

Références

Arch Biochem Biophys. 2019 Mar 30;664:134-148
pubmed: 30742801
J Phys Chem B. 2019 May 23;123(20):4380-4386
pubmed: 31034772
Biochim Biophys Acta. 2014 Mar;1838(3):853-8
pubmed: 24316000
Acta Neuropathol. 1998 Nov;96(5):445-52
pubmed: 9829807
PLoS One. 2018 Jun 14;13(6):e0198767
pubmed: 29902210
Ann Pharmacother. 2020 May;54(5):470-477
pubmed: 31735059
J Biomol NMR. 2010 Oct;48(2):113-21
pubmed: 20734112
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Sci Rep. 2017 Jan 23;7:41051
pubmed: 28112214
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
Cold Spring Harb Protoc. 2018 Jun 1;2018(6):
pubmed: 29858337
Sci Adv. 2020 Oct 2;6(40):
pubmed: 33008896
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):3-7
pubmed: 23227278
J Neuroinflammation. 2018 Jun 4;15(1):172
pubmed: 29866153
Neurology. 2013 May 7;80(19):1778-83
pubmed: 23390181
PLoS One. 2014 Mar 05;9(3):e90659
pubmed: 24599158
Nat Commun. 2018 Feb 19;9(1):712
pubmed: 29459792
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050
pubmed: 32695874
Annu Rev Biochem. 2017 Jun 20;86:27-68
pubmed: 28498720
J Am Chem Soc. 2017 Jul 5;139(26):8828-8836
pubmed: 28573847
Int J Mol Sci. 2021 Nov 17;22(22):
pubmed: 34830264
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Amyloid. 2017 Mar;24(1):1-16
pubmed: 28393556
Biochim Biophys Acta. 2013 Jan;1835(1):100-9
pubmed: 23123827
Protein Sci. 2010 Sep;19(9):1686-91
pubmed: 20629174
ACS Chem Neurosci. 2017 Oct 18;8(10):2152-2158
pubmed: 28759719
J Biol Chem. 2020 May 22;295(21):7470-7480
pubmed: 32291284
J Biol Chem. 1998 May 15;273(20):12427-35
pubmed: 9575199
Sci Rep. 2018 Aug 27;8(1):12836
pubmed: 30150640
Chem Sci. 2020 Jun 17;11(27):7031-7039
pubmed: 34122996
Expert Opin Investig Drugs. 2017 Jun;26(6):735-739
pubmed: 28460541
Neurosci Lett. 2019 Apr 23;699:199-205
pubmed: 30753908
Int J Mol Sci. 2020 Nov 24;21(23):
pubmed: 33255444
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Neurosci Lett. 1998 Jun 19;249(2-3):180-2
pubmed: 9682846
Biochim Biophys Acta Proteins Proteom. 2019 Jul - Aug;1867(7-8):701-709
pubmed: 31096048
Biophys Chem. 2009 Mar;140(1-3):9-15
pubmed: 19101068
Mol Pharm. 2012 Apr 2;9(4):1024-9
pubmed: 22376087
J Mol Biol. 2002 Feb 15;316(2):265-76
pubmed: 11851337
J Biol Chem. 2016 Oct 21;291(43):22618-22629
pubmed: 27587396
Prion. 2012 Apr-Jun;6(2):184-90
pubmed: 22460692
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3841-6
pubmed: 23431180
Int J Mol Sci. 2012;13(3):2893-917
pubmed: 22489132
PCR Methods Appl. 1994 Dec;4(3):S131-6
pubmed: 7580894
Nat Commun. 2013;4:2575
pubmed: 24108358
Nat Struct Mol Biol. 2016 May;23(5):409-15
pubmed: 27018801
Curr Biol. 2014 Oct 6;24(19):2319-26
pubmed: 25264250
Protein Sci. 2017 Mar;26(3):436-451
pubmed: 28019676
Sci Rep. 2020 Feb 14;10(1):2640
pubmed: 32060391
J Chem Theory Comput. 2008 Jan;4(1):116-22
pubmed: 26619985
Nat Neurosci. 2017 Nov;20(11):1569-1579
pubmed: 28945221
Biochim Biophys Acta. 2007 Sep;1767(9):1073-101
pubmed: 17692815
Nat Protoc. 2016 Aug;11(8):1414-27
pubmed: 27414758
Biochemistry. 2009 Sep 15;48(36):8578-84
pubmed: 19655784
Mol Biotechnol. 2004 Jan;26(1):27-34
pubmed: 14734821
Int J Mol Sci. 2021 Jul 26;22(15):
pubmed: 34360737
Molecules. 2020 Jan 29;25(3):
pubmed: 32013170
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
Biochim Biophys Acta Biomembr. 2018 Sep;1860(9):1848-1853
pubmed: 29626444
Nat Commun. 2019 Dec 4;10(1):5535
pubmed: 31797870
Acta Neuropathol. 2014 Apr;127(4):507-22
pubmed: 24240735
J Leukoc Biol. 1993 Feb;53(2):197-204
pubmed: 8445331
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15871-6
pubmed: 16247008
Intrinsically Disord Proteins. 2013 Jan 1;1(1):18-39
pubmed: 24634806
Biochim Biophys Acta. 2016 Nov;1864(11):1558-69
pubmed: 27524699
Int J Biol Macromol. 2016 Feb;83:433-41
pubmed: 26601760
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
ACS Chem Neurosci. 2016 Jan 20;7(1):34-9
pubmed: 26550994
Acta Neuropathol. 2020 Jun;139(6):977-1000
pubmed: 32356200
Commun Biol. 2020 Jul 9;3(1):365
pubmed: 32647130
J Biomol NMR. 2020 Sep;74(8-9):365-379
pubmed: 32651751

Auteurs

Zigmantas Toleikis (Z)

Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
Life Sciences Center, Institute of Biotechnology, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Raitis Bobrovs (R)

Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.

Agne Janoniene (A)

Life Sciences Center, Institute of Biotechnology, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Alons Lends (A)

Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.

Mantas Ziaunys (M)

Life Sciences Center, Institute of Biotechnology, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Ieva Baronaite (I)

Life Sciences Center, Institute of Biotechnology, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Vytautas Petrauskas (V)

Life Sciences Center, Institute of Biotechnology, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Kristine Kitoka (K)

Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.

Vytautas Smirnovas (V)

Life Sciences Center, Institute of Biotechnology, Vilnius University, Saulėtekio 7, 10257 Vilnius, Lithuania.

Kristaps Jaudzems (K)

Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH